FDA Approval for Vorinostat. Use in Cancer. Vorinostat is approved to treat: Cutaneous T-cell lymphoma that has not gotten better with other chemotherapy or that has ...
(vor-IN-o-stat) Trade Name: Zolinza. Drug Type: Vorinostat is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Vorinostat is classified as an ...
Easy to read patient leaflet for vorinostat. Includes indications, proper use, special instructions, precautions, and possible side effects.
Vorinostat also known as suberanilohydroxamic acid (suberoyl+anilide+hydroxamic acid abbreviated as SAHA) is a member of a larger class of compounds that inhibit ...
With a steady focus on innovation and sound science, we work to deliver vaccines, medications, and consumer and animal health products that can help millions around ...
Vorinostat | C14H20N2O3 | CID 5311 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety ...
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE ... Vorinostat was not evaluated in patients with renal impairment. However, renal excretion does not
Vorinostat also known as SAHA, Zolinza, MK-0683 is an HDAC inhibitor. Vorinostat CAS No 149647-78-9 with purity >99% & solubility DMSO is available. Find all the ...
The NCI Drug Dictionary contains technical definitions and synonyms for drugs/agents used to treat patients with cancer or conditions related to cancer.
Zolinza official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.